Your browser doesn't support javascript.
loading
Uveal Melanoma UK National Guidelines.
Nathan, P; Cohen, V; Coupland, S; Curtis, K; Damato, B; Evans, J; Fenwick, S; Kirkpatrick, L; Li, O; Marshall, E; McGuirk, K; Ottensmeier, C; Pearce, N; Salvi, S; Stedman, B; Szlosarek, P; Turnbull, N.
Affiliation
  • Nathan P; Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: nathan.pd@gmail.com.
  • Cohen V; Ocular Oncology Service, St Bartholomew's and Moorfields Eye Hospital, London, UK.
  • Coupland S; Department Molecular and Clinical Cancer Medicine, University of Liverpool, UK.
  • Curtis K; OcuMel UK, UK.
  • Damato B; Royal Liverpool University Hospital, Liverpool, UK.
  • Evans J; Royal Liverpool University Hospital, Liverpool, UK.
  • Fenwick S; University Hospital Aintree, Liverpool, UK.
  • Kirkpatrick L; Patient Representative, UK.
  • Li O; Moorfields Eye Hospital, London, UK.
  • Marshall E; The Clatterbridge Cancer Centre, NHS Foundation Trust, Liverpool, UK.
  • McGuirk K; OcuMel UK, UK.
  • Ottensmeier C; Southampton University Hospitals and University of Southampton, UK.
  • Pearce N; University Hospital Southampton, Southampton, UK.
  • Salvi S; Royal Hallamshire Hospital, Sheffield, UK.
  • Stedman B; Southampton University Hospitals, NHS Trust, Southampton, UK.
  • Szlosarek P; St Bartholomew's Hospital, UK; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Turnbull N; Project Manager, London, UK.
Eur J Cancer ; 51(16): 2404-12, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26278648
ABSTRACT
The United Kingdom (UK) uveal melanoma guideline development group used an evidence based systematic approach (Scottish Intercollegiate Guidelines Network (SIGN)) to make recommendations in key areas of uncertainty in the field including the use and effectiveness of new technologies for prognostication, the appropriate pathway for the surveillance of patients following treatment for primary uveal melanoma, the use and effectiveness of new technologies in the treatment of hepatic recurrence and the use of systemic treatments. The guidelines were sent for international peer review and have been accredited by NICE. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Medical Oncology / Melanoma Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Medical Oncology / Melanoma Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2015 Document type: Article